Yang J, Zhang J, Gu J, Gao M, Zheng M, Guo S
World J Gastroenterol. 2024; 30(42):4532-4543.
PMID: 39563744
PMC: 11572629.
DOI: 10.3748/wjg.v30.i42.4532.
Li P, Xue Y
Front Cell Dev Biol. 2024; 12:1447939.
PMID: 39391349
PMC: 11464462.
DOI: 10.3389/fcell.2024.1447939.
Huang S, Mei Z, Wan A, Zhao M, Qi X
Front Immunol. 2024; 15:1413858.
PMID: 39253075
PMC: 11381393.
DOI: 10.3389/fimmu.2024.1413858.
Wu B, Qi B, Duan L, Chen J
Sci Rep. 2024; 14(1):20713.
PMID: 39237684
PMC: 11377765.
DOI: 10.1038/s41598-024-71377-4.
Luz A, de Medeiros A, de Medeiros G, Piuvezam G, Passos T, de Araujo Morais A
Nutrients. 2024; 16(15).
PMID: 39125281
PMC: 11314321.
DOI: 10.3390/nu16152398.
Comparison among different preclinical models derived from the same patient with a non-functional pancreatic neuroendocrine tumor.
Wang Y, Ye Z, Lou X, Xu J, Jing D, Zhou C
Hum Cell. 2024; 37(5):1522-1534.
PMID: 39078546
DOI: 10.1007/s13577-024-01107-5.
Establishment and characterization of the PDAC-X3 cell line: a novel Chinese-origin pancreatic ductal adenocarcinoma cell line.
Chai C, Tang H, Miao X, Su Y, Li L, Yu C
Hum Cell. 2024; 37(5):1578-1592.
PMID: 39012569
DOI: 10.1007/s13577-024-01100-y.
Combining single-cell and bulk RNA sequencing, NK cell marker genes reveal a prognostic and immune status in pancreatic ductal adenocarcinoma.
Ouyang Y, Shen R, Chu L, Fu C, Hu W, Huang H
Sci Rep. 2024; 14(1):15037.
PMID: 38951569
PMC: 11217423.
DOI: 10.1038/s41598-024-65917-1.
Research insights into the chemokine-like factor (CKLF)-like MARVEL transmembrane domain-containing family (CMTM): their roles in various tumors.
Duan S, Jiang Y, Li G, Fu W, Song Z, Li L
PeerJ. 2024; 12:e16757.
PMID: 38223763
PMC: 10787544.
DOI: 10.7717/peerj.16757.
Exploring the promising potential of induced pluripotent stem cells in cancer research and therapy.
Chehelgerdi M, Dehkordi F, Chehelgerdi M, Kabiri H, Salehian-Dehkordi H, Abdolvand M
Mol Cancer. 2023; 22(1):189.
PMID: 38017433
PMC: 10683363.
DOI: 10.1186/s12943-023-01873-0.
5'-tRF-19-Q1Q89PJZ Suppresses the Proliferation and Metastasis of Pancreatic Cancer Cells via Regulating Hexokinase 1-Mediated Glycolysis.
Cao W, Zeng Z, Lei S
Biomolecules. 2023; 13(10).
PMID: 37892195
PMC: 10605356.
DOI: 10.3390/biom13101513.
Phage-based peptides for pancreatic cancer diagnosis and treatment: alternative approach.
Li Y, Yang K, Duan H, Du Y, Ye J
Front Microbiol. 2023; 14:1231503.
PMID: 37601380
PMC: 10433397.
DOI: 10.3389/fmicb.2023.1231503.
Cardiac Organoids: A 3D Technology for Disease Modeling and Drug Screening.
Zhu Y, Yang S, Zhang T, Ge Y, Wan X, Liang G
Curr Med Chem. 2023; 31(31):4987-5003.
PMID: 37497713
DOI: 10.2174/0929867331666230727104911.
PRKRA promotes pancreatic cancer progression by upregulating MMP1 transcription via the NF-κB pathway.
Qiu J, Feng M, Yang G, Su D, Zhao F, Liu Y
Heliyon. 2023; 9(6):e17194.
PMID: 37484321
PMC: 10361375.
DOI: 10.1016/j.heliyon.2023.e17194.
Translation and validation of the Pancreatic Cancer Disease Impact score for Chinese patients with pancreatic cancer: A methodological and cross-sectional study.
Cui L, Yu H, Sun Q, Miao Y, Jiang K, Fang X
Asia Pac J Oncol Nurs. 2023; 10(4):100209.
PMID: 37159609
PMC: 10162946.
DOI: 10.1016/j.apjon.2023.100209.
mutation: The booster of pancreatic ductal adenocarcinoma transformation and progression.
Zhang Z, Zhang H, Liao X, Tsai H
Front Cell Dev Biol. 2023; 11:1147676.
PMID: 37152291
PMC: 10157181.
DOI: 10.3389/fcell.2023.1147676.
Pancreatic Organoids: A Frontier Method for Investigating Pancreatic-Related Diseases.
Liu Y, Li N, Zhu Y
Int J Mol Sci. 2023; 24(4).
PMID: 36835437
PMC: 9959977.
DOI: 10.3390/ijms24044027.
Genetics, Genomics and Emerging Molecular Therapies of Pancreatic Cancer.
Liu J, Mroczek M, Mach A, Stepien M, Aplas A, Pronobis-Szczylik B
Cancers (Basel). 2023; 15(3).
PMID: 36765737
PMC: 9913594.
DOI: 10.3390/cancers15030779.
The Anti-Tubercular Aminolipopeptide Trichoderin A Displays Selective Toxicity against Human Pancreatic Ductal Adenocarcinoma Cells Cultured under Glucose Starvation.
Kasim J, Hong J, Hickey A, Phillips A, Windsor J, Harris P
Pharmaceutics. 2023; 15(1).
PMID: 36678914
PMC: 9866366.
DOI: 10.3390/pharmaceutics15010287.
MicroRNA-543 controls pancreatic cancer development by LINC00847-microRNA-543-STK31 axis.
Liu Y, Wei J, Wang C, Meng Z, Luo D, Zhao X
J Gastrointest Oncol. 2023; 13(6):3263-3277.
PMID: 36636045
PMC: 9830362.
DOI: 10.21037/jgo-22-1017.